Making CAR T-cell therapies more affordable
CAR T-cell therapies have revolutionised treatment of many diseases, but their expense means many patients are unable to benefit. Kathryn Senior reports.
CAR T-cell therapies have revolutionised treatment of many diseases, but their expense means many patients are unable to benefit. Kathryn Senior reports.
President-elect Donald Trump said he plans to “knock out” drug-industry middlemen, a sign the sector isn’t likely to see relief from political scrutiny.
To identify risk factors associated with major adverse cardiovascular events (MACE) and malignancies in patients with rheumatoid arthritis (RA) using real‐world data from Japan. This…
A new study shows taxi drivers die at lower rates from Alzheimer’s disease than people with other professions.
The flight test revealed that the drone was able to fly for over three hours in the airspace over Changhai county.
In this episode of Supply Chain Now, host Scott W. Luton sits down with David Morin, Vice President of Client & Retail Strategy at Narvar,…
Recent legal and regulatory uncertainty has led to concerns about the long-term viability and efficacy of certain types of physician-led health care structures as an…
Service promised by 2030 for bloc’s take on Starlink
T-Mobile and Starlink are marching forward with their plan to offer cell service via satellite. The provider is opening up registrations for anyone who wants…
I hope you are preparing for a beautiful family Christmas celebration. But are you up at night worrying about the drones? Reports of mysterious objects…
Although Disney princesses seem to live happily ever after, they face serious real world health hazards, warn experts in the Christmas issue of The BMJ.